|
PDXP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.468980E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.352400E-02 |
| Normal-vs-Stage2 |
2.718400E-01 |
| Normal-vs-Stage3 |
1.414790E-01 |
| Normal-vs-Stage4 |
6.045700E-02 |
| Stage1-vs-Stage2 |
2.780500E-03 |
| Stage1-vs-Stage3 |
9.709200E-01 |
| Stage1-vs-Stage4 |
4.487400E-01 |
| Stage2-vs-Stage3 |
1.050060E-02 |
| Stage2-vs-Stage4 |
7.961700E-03 |
| Stage3-vs-Stage4 |
4.850400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.098300E-02 |
| Normal-vs-AfricanAmerican |
9.433900E-02 |
| Normal-vs-Asian |
7.992600E-01 |
| Caucasian-vs-AfricanAmerican |
4.581600E-01 |
| Caucasian-vs-Asian |
1.778790E-01 |
| AfricanAmerican-vs-Asian |
1.808980E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.560000E-02 |
| Normal-vs-Female |
2.763800E-01 |
| Male-vs-Female |
6.319800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.614400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.780620E-01 |
| Normal-vs-Age(61-80Yrs) |
5.147600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.006620E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.597600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.565560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.815800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.914800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.553800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.813700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.674000E-01 |
| Classical-VS-Follicular |
7.319800E-01 |
| Classical-VS-Other |
3.110600E-01 |
| Classical-VS-Normal |
1.434160E-01 |
| Tall-VS-Follicular |
3.377400E-01 |
| Tall-VS-Other |
6.234800E-01 |
| Tall-VS-Normal |
8.436200E-02 |
| Follicular-VS-Other |
3.650600E-01 |
| Follicular-VS-Normal |
3.630200E-01 |
| Other-VS-Normal |
1.316960E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.143800E-01 |
| Normal-vs-N1 |
5.824300E-03 |
| N0-vs-N1 |
9.541700E-03 |
|
|
